<DOC>
	<DOCNO>NCT01028690</DOCNO>
	<brief_summary>Helicobacter pylorus colonize approximately 50 % world-wide population . There exigency find route alternate control infection ample perspective without complication induction resistance antibiotic . Supplement dietetic Lactobacillus reuteri ( L. reuteri ) humans take colonization epithelium gastric , combine observation L. reuteri capacity inhibit growth H. Pylori union gastric mucosa , indicate potential native human bacteria control influence colonization human . The acid-lactic bacteria ( particular lactobacillus ) study effect human infect H. Pylori success reduce load bacteria Studies use supplement L. reuteri much infect symptomatic patient asymptomatic H. pylorus show clear reduction load bacteria 4 week use concordant reduction symptom associate infection .</brief_summary>
	<brief_title>Control Helicobacter Pylori Infection Dietary Supplementation With Lactobacillus Reuteri</brief_title>
	<detailed_description>The objective study determine dietetic supplementation combination stock L. Reuteri ( L. reuteri Progastria ) effective control load bacteria consequence infection patient infect H. pylorus .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<criteria>Subjects age 18 65 year Infection H. pylorus define âˆ† &gt; 20 ppm UBT test Nonulcer dyspepsia No early eradication therapy H. pylori infection Written inform consent Stated availability throughout entire study period Mental ability understand willingness fulfil detail protocol Duodenal gastric ulcer MALT lymphoma Penicillin allergy Gastric resection ( time ) First level relative gastric cancer patient Absence GI symptom Use NSAIDs , aspirin antiinflammatory drug within 1 week ( occasional use ) 3 week ( chronic use ) inclusion Use oral antibiotic and/or PPIs and/or H2antagonists 2 week prior ingestion study product Pregnancy Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Eradication therapy</keyword>
	<keyword>Lactobacillus reuteri</keyword>
	<keyword>Dyspeptic symptom</keyword>
</DOC>